A Study of HS-20089 in Patients With Advanced Solid Tumors

Clinical trial NCT05263479 · RECRUITING

Trial details

NCT number: NCT05263479
Sponsor: Shanghai Hansoh Biomedical Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-01-05
Primary completion: 2024-12-31
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.